AURA

Aura Biosciences Inc
11.045
-0.165 (-1.47%)

Aura Biosciences Inc. (AURA) Fundamentals

Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.
SHARE INFORMATION
Market Cap$ 375,212,455
Shares Outstanding37,039,729
Float27,592,026
Percent Float74.49%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -9.27
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions118
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months1,552,709
Institutional Holdings Percent54.5%
Institutional Sold Previous 3 Months142,196
Insider Holdings Date2023-01-31
Insider Bought Previous 3 Months1,889,000
Insider Holdings Percent1.1
Insider Sold Previous 3 Months10,508
Insider Shares Owned410,849
TRADING INFO
52 Week High$ 24.83
52 Week Low$ 9.43
52 Week High Change$ -44.34
21 Day Moving Average$ 10.5229
21 Day Extended Moving Average$ 10.5421
50 Day Moving Average$ 11.4454
50 Day Extended Moving Average$ 11.2686
200 Day Moving Average$ 14.0448
200 Day Extended Moving Average$ 13.646
10 Day Average Volume116,296
20 Day Average Volume102,187
30 Day Average Volume93,657
50 Day Average Volume104,794
Alpha-0.005289
Beta0.1005
Standard Deviation0.189710
R20.001134
7 Day Price Change$ 0.06
7 Day Percent Change0.6%
21 Day Price Change$ -1.27
21 Day Percent Change-11.14%
30 Day Price Change$ -0.54
30 Day Percent Change-5.06%
Month to Date Price Change$ -0.28
Month to Date Percent Change-2.69%
Quarter to Date Price Change$ -0.37
Quarter to Date Percent Change-3.52%
180 Day Price Change$ -3.87
180 Day Percent Change-27.64%
200 Day Price Change$ -3.56
200 Day Percent Change-26.0%
Year to Date Price Change$ -0.37
Year to Date Percent Change-3.52%

Aura Biosciences Inc. (AURA) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.30
Total Debt To Equity0.20
Int Coverage-28,523.00
Current Ratio11.60
Leverage Ratio1.10
Quick Ratio11.20
Long Term Debt To Capital0.14
VALUATION MEASURES
PE Ratio-1.10
Enterprise Value$ 284,764,454
Price to Sales0.00
Price to Free Cash-10.10
PE High Last 5 Years0.00
Price To Book3.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book3.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-47.17
Return on Equity691.10
Return on Capital-1,249.29

Aura Biosciences Inc. (AURA) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOElisabet de los Pinos
Emplyoees52
Last AuditUQ
CIK0001501796
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address85 Bolton Street
Cambridge, MA 2140
Websitehttps://www.aurabiosciences.com
Facsimile-
Telephone+1 617 500-8864
Email-


Your Recent History
NASDAQ
AURA
Aura Biosc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.